Share Your Innovative Tools, Techniques, and Strategies
Preparations for the March 2019 ISPE Aseptic Conference in Bethesda, MD, USA are in full swing! Take this opportunity to share your story or case study showcasing a successful project, lessons learned, or challenges overcome with fellow pharmaceutical professionals in Aseptic processing. We are actively soliciting proposals in the following areas:
Emerging and Trending Technology
Single-Use Technology
Flexible and Multi-Product Facilities
Aging Facilities and Upgrades/Renovations
Robotics
Small Batches and Personal Medicine/Modular Technology
Containment and Sterility, Cleaning, and Cross Contamination Prevention
Learn more about each of these topic areas by visiting the 2019 ISPE Aseptic Conference Call for Proposals page which gives an in-depth description of each topic area along with instructions on how to submit a proposal.
In addition to our signature content of barrier/isolator technology and disposables, this year’s conference also includes sessions on these hot topics:
Containment of highly potent/toxic aseptic processing
Evolving technologies like production of cell and gene therapy products
Use of robots in cleanroom applications
Another conference highlight attendees look forward to is the interactive panel discussion with FDA and this year is shaping up to provide timely and relevant discussion you’ll want to experience first-hand.
There will be plenty of opportunities to discuss and network with pharma professionals in Aseptic processing in interactive education sessions and during breaks in the exhibit hall.
Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.
Jörg Zimmermann is currently Vice President External Affairs for Vetter Pharma Fertigung GmbH&Co KG, Ravensburg, Germany. In this role, he manages the relationships with regulatory...
Are you considering joining ISPE? Or maybe you’ve recently joined the society or are a longtime member looking to better understand all the benefits available to you. If so, you’ve come to the right place!
ATMPs are based on genes, cells or tissues delivered to patients to provide a therapeutic benefit based on a specific target of interest. Often referred to as ‘Personalised Medicine’. A sector of healthcare that is rapidly evolving and expanding with some unique challenges such as microbial contamination and product variability. Traditional manufacturing processes are for synthetically derived...
GAMP® 5 Second Edition is here! Since its publication, GAMP® 5 has been far and away the leading international guidance on GxP computerized systems validation and compliance, and it was time to update our guidance to...